Get the Stockscreener App
1.58
5.33%
0.08
After Hours:
1.59
0.01
+0.63%
Nls Pharmaceutics Ltd Stock (NLSP) Forecast
The Nls Pharmaceutics Ltd (NLSP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.4315, representing a -9.40% decrease from the current price of $1.58. The highest analyst price target is $1.4764, and the lowest is $1.3866.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NLSP Price Target
Average 1.118
(-29.24% Downside)
Is Nls Pharmaceutics Ltd (NLSP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 56.45 | Neutral |
| STOCH(9,6) | 66.87 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.00957 | Buy |
| ADX(14) | 10.79 | Neutral |
| William %R | -8.6748 | Sell |
| CCI(14) | 159.26 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.4897
Buy
|
1.4975
Buy
|
| MA20 |
1.453
Buy
|
1.4897
Buy
|
| MA50 |
1.5529
Buy
|
1.6226
Sell
|
| MA100 |
1.8131
Sell
|
2.1679
Sell
|
| MA200 |
3.6562
Sell
|
3.976
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, NLSP could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on NLSP, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 56.45 indicates that NLSP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 66.87 indicates that NLSP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that NLSP is oversold. This suggests that NLSP price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 10.79 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 159.26 indicates that NLSP is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term NLSP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nls Pharmaceutics Ltd financial reports and earnings history, Nls Pharmaceutics Ltd (NLSP) stock could reach $2.6054 by 2030, $11.16 by 2040 and $1.317 by 2050. See the projected annual prices until 2050 of the Nls Pharmaceutics Ltd stock below:
- Nls Pharmaceutics Ltd (NLSP) is expected to reach an average price of $0.693 in 2035, with a high prediction of $0.8324 and a low estimate of $0.7315. This indicates an $-56.14% rise from the last recorded price of $1.58.
- Nls Pharmaceutics Ltd (NLSP) stock is projected to chart a bullish course in 2040, with an average price target of $11.04, representing an $599.00% surge from its current level. The forecast ranges from a conservative $11.16 to a sky-high $11.16.
- Our analysts predict Nls Pharmaceutics Ltd (NLSP) to jump 305.97% by 2045, soaring from $6.5643 to an average price of $6.4143, potentially reaching $6.6931. While $6.5643 is the low estimate, the potential upside is significant.
- Nls Pharmaceutics Ltd (NLSP) stock is expected to climb by 2050, reaching an average of $0.9936, a $-37.11% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.317 and $1.0029, respectively, highlighting the market's uncertainty.
Nls Pharmaceutics Ltd Stock (NLSP) Year by Year Forecast
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2025
Nls Pharmaceutics Ltd Stock (NLSP) is expected to reach an average price of $0.859 in 2025, with a high prediction of $1.4764 and a low estimate of $0.2415. This indicates an -45.64% fall from the last recorded price of $1.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $1.1366 | $1.3866 | $1.4764 | -28.06% |
| July, 2025 | $1.0136 | $1.0071 | $1.0934 | -35.85% |
| August, 2025 | $1.0072 | $0.8538 | $0.8138 | -36.25% |
| September, 2025 | $1.4809 | $1.164 | $1.182 | -6.27% |
| October, 2025 | $1.3576 | $1.4512 | $1.381 | -14.07% |
| November, 2025 | $1.3842 | $1.4487 | $1.3246 | -12.39% |
| December, 2025 | $1.5186 | $1.3616 | $1.4285 | -3.89% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2026
The predicted value for Nls Pharmaceutics Ltd (NLSP) in 2026 is set at an average of $0.7353. Estimates vary from a peak of $1.4618 to a trough of $0.00882, indicating an -53.46% surge from the present price of $1.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.3136 | $1.362 | $1.4618 | -16.86% |
| February, 2026 | $0.8559 | $0.9432 | $1.2554 | -45.83% |
| March, 2026 | $1.1692 | $0.909 | $0.9954 | -26.00% |
| April, 2026 | $1.1238 | $1.1494 | $1.0828 | -28.87% |
| May, 2026 | $0.6949 | $0.7596 | $0.8996 | -56.02% |
| June, 2026 | $0.1834 | $0.4533 | $0.5132 | -88.39% |
| July, 2026 | $0.0904 | $0.00982 | $0.4398 | -94.28% |
| August, 2026 | $0.076 | $0.00882 | $0.146 | -95.19% |
| September, 2026 | $0.0215 | $0.0274 | $0.4858 | -98.64% |
| October, 2026 | $0.3454 | $0.0356 | $0.4054 | -78.14% |
| November, 2026 | $0.0318 | $0.0632 | $0.392 | -97.99% |
| December, 2026 | $0.0649 | $0.045 | $0.0484 | -95.90% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nls Pharmaceutics Ltd (NLSP) is $0.2775, with a high forecast of $0.5546 and a low forecast of $0.000261. This indicates an -82.44% decrease from the last price of $1.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.06 | $0.0234 | $0.5546 | -96.21% |
| February, 2027 | $0.00245 | $0.0484 | $0.2244 | -99.84% |
| March, 2027 | $0.3807 | $0.00405 | $0.3907 | -75.91% |
| April, 2027 | $0.0429 | $0.0105 | $0.4123 | -97.28% |
| May, 2027 | $0.0135 | $0.000261 | $0.3053 | -99.15% |
| June, 2027 | $0.1933 | $0.0433 | $0.099 | -87.76% |
| July, 2027 | $0.0471 | $0.1103 | $0.1667 | -97.02% |
| August, 2027 | $0.0593 | $0.00428 | $0.1227 | -96.25% |
| September, 2027 | $0.0923 | $0.00402 | $0.1223 | -94.16% |
| October, 2027 | $0.0463 | $0.0321 | $0.1589 | -97.07% |
| November, 2027 | $0.0649 | $0.00189 | $0.1201 | -95.89% |
| December, 2027 | $0.0222 | $0.0315 | $0.0467 | -98.59% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2028
In 2028, Nls Pharmaceutics Ltd (NLSP) is projected to reach an average price of $1.8348, with a high projection of $3.6553 and a low estimate of $0.0143. This indicates an +16.13% rise from the last price of $1.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.7058 | $0.0143 | $2.9458 | +134.54% |
| February, 2028 | $2.663 | $2.3762 | $3.3826 | +68.54% |
| March, 2028 | $2.697 | $2.4766 | $2.617 | +70.69% |
| April, 2028 | $2.6842 | $2.839 | $2.6744 | +69.88% |
| May, 2028 | $2.7182 | $2.741 | $2.6683 | +72.04% |
| June, 2028 | $2.7654 | $2.815 | $2.7018 | +75.02% |
| July, 2028 | $3.3425 | $3.0021 | $3.1222 | +111.55% |
| August, 2028 | $2.7765 | $3.0015 | $3.1961 | +75.73% |
| September, 2028 | $2.9737 | $2.9931 | $2.8637 | +88.21% |
| October, 2028 | $3.1109 | $2.9373 | $2.9209 | +96.89% |
| November, 2028 | $3.0749 | $3.0877 | $3.1782 | +94.61% |
| December, 2028 | $3.6321 | $3.7321 | $3.6553 | +129.88% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2029
The 2029 price forecast for Nls Pharmaceutics Ltd Stock (NLSP) is $3.2554 on average, with a high prediction of $3.8629 and a low estimate of $2.648. This represents an +106.04% increase from the previous price of $1.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.9661 | $3.8025 | $3.8484 | +151.02% |
| February, 2029 | $3.4733 | $3.7233 | $3.8629 | +119.83% |
| March, 2029 | $3.1705 | $3.2774 | $3.4001 | +100.66% |
| April, 2029 | $3.0477 | $3.0577 | $3.0177 | +92.89% |
| May, 2029 | $3.6018 | $3.2445 | $3.3029 | +127.96% |
| June, 2029 | $3.4288 | $3.5288 | $3.4621 | +117.02% |
| July, 2029 | $3.366 | $3.4699 | $3.3292 | +113.04% |
| August, 2029 | $3.379 | $3.2832 | $3.3197 | +113.86% |
| September, 2029 | $3.1802 | $3.2572 | $3.3336 | +101.28% |
| October, 2029 | $2.6115 | $2.6988 | $3.0608 | +65.29% |
| November, 2029 | $2.8584 | $2.648 | $2.6846 | +80.91% |
| December, 2029 | $2.7028 | $2.7806 | $2.7554 | +71.06% |
Nls Pharmaceutics Ltd Stock (NLSP) Price Forecast for 2030
Nls Pharmaceutics Ltd Stock (NLSP) is expected to reach an average price of $1.632 in 2030, with a high forecast of $2.6054 and a low forecast of $0.6587. This signifies an +3.29% surge from the last price of $1.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.2347 | $2.2994 | $2.6054 | +41.44% |
| February, 2030 | $1.6568 | $1.9267 | $2.0364 | +4.86% |
| March, 2030 | $1.4007 | $1.424 | $1.2141 | -11.35% |
| April, 2030 | $1.2812 | $1.385 | $1.3008 | -18.91% |
| May, 2030 | $1.0151 | $1.0651 | $1.1848 | -35.75% |
| June, 2030 | $0.8223 | $0.9803 | $0.9719 | -47.95% |
| July, 2030 | $1.0763 | $0.8991 | $1.0463 | -31.88% |
| August, 2030 | $1.1535 | $1.1199 | $1.0467 | -26.99% |
| September, 2030 | $0.9806 | $0.9987 | $1.0303 | -37.94% |
| October, 2030 | $0.8948 | $0.9573 | $0.9843 | -43.37% |
| November, 2030 | $0.6319 | $0.8219 | $0.8383 | -60.01% |
| December, 2030 | $0.7491 | $0.6587 | $0.6523 | -52.59% |
0.47%
2.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):